SCHEMBL228973

SCHEMBL228973

CCC(CC)(CO)C(C)O

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
DPP4 P27487 1/20 0.33
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9522456 0.94 TSHR (0.35) TSHRTDP1DPP4ALDH1A1LMNA
SCHEMBL16074804 0.85 DPP4 (0.33) DPP4
SCHEMBL10988323 0.85
SCHEMBL10892870 0.84 TSHR (0.41) TSHRTDP1ALDH1A1LMNA
SCHEMBL932773 0.84 TDP1 (0.41) TSHRTDP1DPP4ALDH1A1LMNA
SCHEMBL406532 0.81 ALDH1A1 (0.31) ALDH1A1
SCHEMBL8516706 0.79
SCHEMBL20224768 0.79 DPP4 (0.35) TSHRTDP1DPP4ALDH1A1
SCHEMBL765917 0.79 DPP4 (0.35) TSHRTDP1DPP4ALDH1A1
SCHEMBL7047457 0.79 DPP4 (0.35) TSHRTDP1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663538-B2 Aluminum compound, thin-film forming raw material, and method for producing thin film ADEKA CORPORATION (JP) 2017-05-30 US claimed
CN-1110541-C Concentrated water-dispersible stable fiber softener compositions PROCTER & GAMBLE (US) 2003-06-04 CN claimed
CN-1098350-C Fabric softening compound/composition PROCTER & GAMBLE (US) 2003-01-08 CN claimed
CN-1244212-A Improved expression vectors PROCTER & GAMBLE (US) 2000-02-09 CN claimed
CN-1219953-A Fabric softening compound/composition PROCTER & GAMBLE (US) 1999-06-16 CN claimed
CN-1196081-A Concentrated, water dispersible, stable, fabric softening compositions PROCTER & GAMBLE (US) 1998-10-14 CN claimed
CN-1195369-A Concentrated and stable fabric softening compositions PROCTER & GAMBLE (US) 1998-10-07 CN claimed
EP-0273390-B1 Radiation curable resin composition for use in magnetic recording media MITSUBISHI RAYON CO (JP) 1996-08-14 EP claimed
US-12630570-B2 Organometallic adduct compound and method of manufacturing integrated circuit device by using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-05-19 US disclosed
EP-4130010-B1 ZINC COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, THIN FILM, AND METHOD FOR PRODUCING THIN FILM ADEKA CORP (JP) 2026-04-29 EP disclosed
EP-4067365-B1 COMPOUND, THIN FILM-FORMING MATERIAL, AND METHOD FOR PRODUCING THIN FILM ADEKA CORP (JP) 2026-03-25 EP disclosed
US-12577660-B2 Compound, thin-film forming raw material, thin-film, and method of producing thin-film ADEKA CORPORATION (JP) 2026-03-17 US disclosed
US-20260055507-A1 THIN-FILM FORMING RAW MATERIAL, THIN-FILM AND METHOD OF PRODUCING THIN-FILM ADEKA CORPORATION (JP) 2026-02-26 US disclosed
US-20260055506-A1 HALOGEN COMPOUND ADEKA CORPORATION (JP) 2026-02-26 US disclosed
US-4017652-A Photocatalyst system and ultraviolet light curable coating compositions containing the same PPG INDUSTRIES, INC. (US) 1977-04-12 US disclosed
US-4005244-A Ultraviolet light curable opacifying compositions PPG INDUSTRIES, INC. (US) 1977-01-25 US disclosed
US-3984726-A Ultraviolet light system having means for maintaining constant intensity light profile PPG INDUSTRIES, INC. (US) 1976-10-05 US disclosed
US-3960936-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS, SKIN DISORDERS SYNTEX CORPORATION (PM) 1976-06-01 US disclosed
US-3947472-A ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC SYNTEX CORPORATION (PM) 1976-03-30 US disclosed
US-3935273-A ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC SYNTEX CORPORATION (US) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055506-A1 HALOGEN COMPOUND SLC9A2, SLC9A1, SLC9B2 TSHR 261/4885TDP1 3882/4885DPP4 3743/4885
US-12630570-B2 Organometallic adduct compound and method of manufacturing integrated circuit device by using the same C5, AFF2, AFF4 TSHR 2193/4885TDP1 3376/4885DPP4 4493/4885
US-20260055507-A1 THIN-FILM FORMING RAW MATERIAL, THIN-FILM AND METHOD OF PRODUCING THIN-FILM TMEM109, FTO, YTHDF2 TSHR 2702/4885TDP1 2954/4885DPP4 3930/4885
US-12577660-B2 Compound, thin-film forming raw material, thin-film, and method of producing thin-film METTL14, YTHDF2, YTHDF1 TSHR 3127/4885TDP1 1640/4885DPP4 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.